Replace The HumansAI agents & platforms, verified

Recursion Pharmaceuticals

Publicly traded AI drug discovery company that merged with Exscientia in a $688M all-stock deal (closed Nov 2024), combining biological screening (Recursion) with precision chemistry/automated synthesis (Exscientia).

Independenthigh confidenceVerified 2026-08-01

This is where the depth lives — everything below is evidence-graded

How the product is positioned

Publicly traded AI drug discovery company that merged with Exscientia in a $688M all-stock deal (closed Nov 2024), combining biological screening (Recursion) with precision chemistry/automated synthes

Our summary of the vendor’s positioning — verbatim claim not yet recorded

What we found

Level 1 · assistive

Seeded at the rubric default. No independent evidence of end-to-end task completion has been reviewed yet, so the lowest grade applies until it is.

Any human checkpoint here is a product setting, not a regulatory requirement — confirm how it is configured for your deployment.

Graded 2026-08-01 · re-check 2026-11-01

Procurement detail

Deployment
saasvendor documentation
Compliance
GxP-aligned R&D processesreport dates not disclosed — request before signing
Integrations
Internal automated wet-lab and computational infrastructure claim unverified
Pricing
customRevenue from pharma partnerships and milestone/royalty deals; not consumer-priced.
Human checkpoint
Requiredproduct setting
Named customers
Multiple pharma partners across 10+ partnered programs (not individually detailed in sources)from cited sources

Will they still be here?

Independent
Funding
NASDAQ: RXRX; merged with Exscientia ($688M all-stock deal, closed Nov 2024); $450M+ in partner milestone payments received to date
Founded
2013
HQ
Salt Lake City, USA

Sources

Logo retrieved 2026-08-01from the vendor’s own site · trademark of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX)

Where it’s weak

Post-merger integration risk and pipeline rework reported months after the deal closed; public-market scrutiny on cash burn versus pipeline progress.

Corrections

Vendors may submit factual corrections free of charge. We correct facts and publish the change. We do not accept payment to change a grade. Submit a correction →